Anh Dinh

National Institutes of Health Clinical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors”.

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors

Journal of Translational Medicine(2022)10.1186/s12967-022-03751-7

N/A

0.781DataRank · unranked

18 citations

Patrick Danaher, Lipei Shao, Martin Ongkeko, Leo Chen, Anh Dinh +12 more

An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.28.538590

N/A

0.330DataRank · unranked

8 citations

Karl A. Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George Eng, Erika D. Handly +15 more

The need for uniform and coordinated practices involving centrally manufactured cell therapies

Journal of Translational Medicine(2022)10.1186/s12967-022-03385-9

N/A

0DataRank · unranked

8 citations

Anh Dinh, Herleen Rai, Nan Zhang, R.P. Somerville, Sandhya R. Panch +1 more

Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays

Cytotherapy(2023)10.1016/j.jcyt.2023.02.010

N/A

0DataRank · unranked

12 citations

Lipei Shao, Tatyana Fuksenko, Hui Liu, Rongye Shi, Anh Dinh +7 more

Healthcare center‐based cell therapy laboratories supporting off‐site manufactured cell therapies: The experiences of a single academic cell therapy laboratory

Transfusion(2024)10.1111/trf.17703

N/A

0DataRank · unranked

5 citations

David F. Stroncek, Anh Dinh

Expanding the reach of commercial cell therapies requires changes at medical centers

Journal of Translational Medicine(2024)10.1186/s12967-024-04966-6

N/A

0DataRank · unranked

2 citations

Nan Zhang, Jiaqiang Ren, R.P. Somerville, Anh Dinh, David F. Stroncek

Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci; addressing the need for deceased donor expedited HLA typing

Human Immunology(2020)10.1016/j.humimm.2020.06.004

N/A

0DataRank · unranked

67 citations

Amalia Dinou, Jamie L. Duke, Deborah Ferriola, Hilary Mehler, Ioanna Pagkrati +8 more

Stability testing of HPCs and MNCs from apheresis products

Immunobiology(2025)10.1016/j.imbio.2025.153112

N/A

0DataRank · unranked

0 citations

Lipei Shao, Tatyana Fuksenko, Hui Liu, Chunjie Jiang, Yihua Cai +9 more

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints

Nature Communications(2020)10.1038/s41467-020-17958-z

N/A

0DataRank · unranked

48 citations

Erik C. Dreaden, Sandra Morandell, Wen Zhou, Sanjeev Dhara, Ganapathy Sriram +13 more